Brief: Mithra Pharmaceuticals signs license and exclusive supply agreement with Fuji Pharma
28/06/2017 06:57
June 28 (Reuters) - MITHRA PHARMACEUTICALS SA MITRA.BR :
* SIGNS LICENSE AND EXCLUSIVE SUPPLY AGREEMENT WITH FUJI
PHARMA FOR DONESTA IN JAPAN AND ASEAN
* DONESTA IS PRODUCT OF MITHRA IN HORMONE THERAPY (HT),
WHOSE PHASE II DOSE RESEARCH STUDY IS CURRENTLY UNDERWAY, MAIN
RESULTS ARE EXPECTED AT END Q1 2018
* CO IS ENTITLED TO EUR 1 MILLION FOR SIGNING, IN ADDITION
TO FUTURE TWO-DIGIT MILESTONES RELATED TO DEVELOPMENT,
REGULATORY ASPECTS AND COMMERCIALIZATION
SOURCE TEXT: http://bit.ly/2sgdWNh
FURTHER COMPANY COVERAGE: MITRA.BR
(Gdynia Newsroom:)
((Gdynia.newsroom@thomsonreuters.com; +48 58 772 09 20;))